Natural Grocers by Vitamin Cottage, Inc.: Form 10-Q for the period ended Dec 31, 2023
Filed with the SEC on Feb 8, 2024 and accepted by EDGAR at Feb 8, 2024, 16:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-10-01 to 2023-12-31 | $301.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Gross profit | 3 months2023-10-01 to 2023-12-31 | $88.8m | us-gaap:GrossProfit |
| Operating income | 3 months2023-10-01 to 2023-12-31 | $10.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-10-01 to 2023-12-31 | $894.0k | us-gaap:InterestExpense |
| Income tax | 3 months2023-10-01 to 2023-12-31 | $2.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-10-01 to 2023-12-31 | $7.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-10-01 to 2023-12-31 | $0.34 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-10-01 to 2023-12-31 | $0.34 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-10-01 to 2023-12-31 | 22,979,744 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-10-01 to 2023-12-31 | $16.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-10-01 to 2023-12-31 | $11.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2023-10-01 to 2023-12-31 | $25.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2023-12-31 | $13.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $143.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $663.2m | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $158.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $509.3m | us-gaap:Liabilities |
| Long-term debt | At period end2023-12-31 | $0 | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-12-31 | $5.7m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-12-31 | $153.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-24-003513. Last ingested by Listed: Nov 4, 2026, 20:03 ET. Listed shows no prices and gives no investment advice.